Company Short-Term Debts: Unity Biotechnology (UBX)

Unity Biotechnology, Inc (UBX) - corporate logo

This daily price chart for Unity Biotechnology (UBX) illustrates the dynamics of a company whose individual short-term debt metrics stand at 0.00. The business relies on global partnerships, which are currently complicated by trade conflicts and raw material import issues. A reputation as a pioneer in anti-aging provides the brand with scientific support and venture interest. Senolytic patents and the complexities of clinical trials establish its fundamental stability.

UBX Unity Biotechnology Inc.: Amount of Current Liabilities in the range 07/04/2022 - 07/19/2025
Signature product of Unity Biotechnology, Inc

This trend reflects liquidity sensitivity to the volume of liabilities maturing within one year, measuring the ability of cash flows to service current credit demands. This calculation is critical for Unity Biotechnology (UBX), as short-term loan debt allows for an assessment of financial stability when paying for biological raw material reserves, which directly impacts the stability of DNA developments and the issuer's overall solvency.

Competitor analysis for Unity Biotechnology

Tempus AI, Inc (TEM) - Company Short-Term Debt|QGEN - Company Short-Term Indebtedness|Ionis Pharma - Company Short-Term Debts|Short-Term Debt Volume Repligen Inc.|Avidity Biosciences (RNA) - Company Current Liabilities|Amount of Current Liabilities crisprtx.com (CRSP)|GeneDx - Company Current Liabilities|Short-Term Debt Ultragenyx Pharmaceutical Inc. RARE|Company Current Liabilities Beam Therapeutics Corp|Company Short-Term Loans and Borrowings Sarepta Corp SRPT|TWST - Company Short-Term Debts|TXG - Company Short-Term Debt|Intellia Therapeutics, Inc. - Company Short-Term Debts|STOK (Stoke Therapeutics Inc) - Short-Term Debt Volume|Company Short-Term Debt BLFS (BioLife Corp)|Short-Term Debt Wave Pharma (WVE)|Company Current Liabilities Maze Therapeutics Inc|Amount of Current Liabilities sionnatx.com (SION)|PRME: Company Short-Term Debts|Short-Term Debt Taysha Gene Therapies Inc TSHA|QURE: Company Short-Term Debts|MGTX - Company Current Liabilities|Company Short-Term Debts REGENXBIO Inc. RGNX|SLDB (solidbio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Ocugen (OCGN)|Company Short-Term Indebtedness PACB|Benitec - Company Short-Term Debt|Short-Term Debt DSGN (Design Corp)|Company Short-Term Debt Rocket Pharmaceuticals RCKT|4dmoleculartherapeutics.com - Company Short-Term Debt|LXEO (Lexeo) - Company Short-Term Debt|KRRO - Short-Term Debt|Company Short-Term Debts EDIT (Editas)|Short-Term Indebtedness Silence Therapeutics Corp|Company Current Liabilities PRQR (ProQR)|Short-Term Debt Codexis Bio (CDXS)|Company Current Liabilities SGMO|Company Short-Term Debts nautilus.bio (NAUT)|Company Short-Term Debts Metagenomi, Inc MGX|DTIL - Company Short-Term Debt|Generation Bio Corp (GBIO) - Company Current Liabilities|BOLD - Company Short-Term Indebtedness|Company Short-Term Debts exicuretx.com|IMNN (Imunon) - Company Short-Term Indebtedness|Company Short-Term Debt Phio Pharmaceuticals Corp (PHIO)|Company Short-Term Indebtedness Mustang Bio Corp|Company Short-Term Debts RNAZ|Company Short-Term Debts bionanogenomics.com BNGO|Company Current Liabilities APDN (Applied DNA Sciences, Inc.)|bluebird bio Inc. - Company Short-Term Debts|ImmunoPrecise (IPA) - Company Short-Term Debt|OMGA - Company Short-Term Indebtedness|Singular Genomics Systems - Company Short-Term Debts|Short-Term Debt Volume regulusrx.com|Syros Pharmaceuticals, Inc. (SYRS) - Company Current Liabilities|Amount of Current Liabilities Telesis Bio Inc. (TBIO)|TRACON - Company Current Liabilities